6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2025-03-29), Glaukos's 6-1 Month Momentum % is -6.45%.
The industry rank for Glaukos's 6-1 Month Momentum % or its related term are showing as below:
GKOS's 6-1 Month Momentum % is ranked worse than 56.84% of 862
companies
in the Medical Devices & Instruments industry
Industry Median: -4.205
vs GKOS: -6.45
Competitive Comparison of Glaukos's 6-1 Month Momentum %
For the Medical Devices subindustry, Glaukos's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glaukos's 6-1 Month Momentum % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Glaukos's 6-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Glaukos's 6-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Glaukos 6-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Glaukos's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GKOS has been successfully added to your